Share Price and Basic Stock Data
Last Updated: March 13, 2026, 8:07 am
| PEG Ratio | -0.74 |
|---|
📊 Last updated
16d ago
Feb 26, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sastasundar Ventures Ltd operates in the Finance & Investments sector, with its stock currently priced at ₹284 and a market capitalization of ₹902 Cr. The company’s revenue trajectory has shown variability over recent quarters. For instance, sales rose from ₹254 Cr in September 2022 to ₹358 Cr in September 2023, reflecting a steady increase. However, the subsequent quarters in 2024 showed a decline, with sales reported at ₹307 Cr in March 2024 and ₹270 Cr in June 2024. This indicates potential volatility in revenue generation, which could stem from market fluctuations or operational challenges. The trailing twelve months (TTM) revenue stood at ₹1,231 Cr, with a year-on-year comparison illustrating a decline from ₹1,060 Cr in March 2023 to ₹1,159 Cr in March 2025. Such trends underscore the need for strategic adjustments to stabilize and enhance revenue growth in the coming periods.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Sastasundar Ventures Ltd | 897 Cr. | 282 | 375/230 | 34.6 | 214 | 0.00 % | 1.33 % | 4.63 % | 10.0 |
| STEL Holdings Ltd | 894 Cr. | 484 | 635/342 | 30.2 | 1,005 | 0.00 % | 1.30 % | 0.97 % | 10.0 |
| Prime Securities Ltd | 915 Cr. | 270 | 325/211 | 33.7 | 67.7 | 0.56 % | 22.6 % | 19.5 % | 5.00 |
| Centrum Capital Ltd | 937 Cr. | 20.4 | 41.9/20.3 | 9.83 | 0.00 % | 8.93 % | 57.6 % | 1.00 | |
| 5Paisa Capital Ltd | 943 Cr. | 302 | 434/288 | 21.7 | 200 | 0.00 % | 13.6 % | 11.9 % | 10.0 |
| Industry Average | 6,937.22 Cr | 1,125.82 | 102.88 | 4,366.07 | 0.41% | 21.71% | 14.20% | 7.23 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 280.63 | 313.15 | 336.05 | 358.49 | 374.50 | 306.67 | 270.29 | 273.53 | 281.29 | 285.84 | 298.43 | 301.32 | 345.74 |
| Expenses | 290.71 | 324.32 | 326.79 | 355.12 | 371.07 | 317.32 | 272.69 | 278.25 | 304.99 | 311.04 | 292.37 | 323.93 | 356.10 |
| Operating Profit | -10.08 | -11.17 | 9.26 | 3.37 | 3.43 | -10.65 | -2.40 | -4.72 | -23.70 | -25.20 | 6.06 | -22.61 | -10.36 |
| OPM % | -3.59% | -3.57% | 2.76% | 0.94% | 0.92% | -3.47% | -0.89% | -1.73% | -8.43% | -8.82% | 2.03% | -7.50% | -3.00% |
| Other Income | 4.01 | 8.63 | 12.11 | 9.71 | 20.13 | 18.46 | 28.75 | -167.39 | -14.06 | 21.91 | 25.38 | 5.34 | 13.62 |
| Interest | 0.27 | 0.26 | 0.25 | 0.24 | 0.24 | 0.27 | 0.10 | 0.06 | 0.05 | 0.01 | 0.09 | 0.04 | 0.17 |
| Depreciation | 2.40 | 2.80 | 2.09 | 2.20 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 |
| Profit before tax | -8.74 | -5.60 | 19.03 | 10.64 | 21.01 | 5.01 | 24.64 | -173.62 | -39.24 | -4.64 | 30.18 | -18.64 | 0.92 |
| Tax % | -70.48% | 287.50% | -28.85% | -23.03% | 3.86% | -583.03% | -102.80% | -13.17% | 1.99% | -478.45% | 11.90% | -17.17% | 59.78% |
| Net Profit | -26.37 | -48.00 | -0.28 | -12.20 | -3.23 | 21.58 | 40.96 | -154.78 | -37.80 | 17.57 | 26.59 | -15.44 | 0.37 |
| EPS in Rs | -6.00 | -10.75 | 0.41 | -2.55 | -0.24 | 5.17 | 9.79 | -34.39 | -8.47 | 4.30 | 7.52 | -3.99 | 0.36 |
Last Updated: March 3, 2026, 2:56 pm
Below is a detailed analysis of the quarterly data for Sastasundar Ventures Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 345.74 Cr.. The value appears strong and on an upward trend. It has increased from 301.32 Cr. (Sep 2025) to 345.74 Cr., marking an increase of 44.42 Cr..
- For Expenses, as of Dec 2025, the value is 356.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 323.93 Cr. (Sep 2025) to 356.10 Cr., marking an increase of 32.17 Cr..
- For Operating Profit, as of Dec 2025, the value is -10.36 Cr.. The value appears strong and on an upward trend. It has increased from -22.61 Cr. (Sep 2025) to -10.36 Cr., marking an increase of 12.25 Cr..
- For OPM %, as of Dec 2025, the value is -3.00%. The value appears strong and on an upward trend. It has increased from -7.50% (Sep 2025) to -3.00%, marking an increase of 4.50%.
- For Other Income, as of Dec 2025, the value is 13.62 Cr.. The value appears strong and on an upward trend. It has increased from 5.34 Cr. (Sep 2025) to 13.62 Cr., marking an increase of 8.28 Cr..
- For Interest, as of Dec 2025, the value is 0.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.04 Cr. (Sep 2025) to 0.17 Cr., marking an increase of 0.13 Cr..
- For Depreciation, as of Dec 2025, the value is 2.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.33 Cr. (Sep 2025) to 2.17 Cr., marking an increase of 0.84 Cr..
- For Profit before tax, as of Dec 2025, the value is 0.92 Cr.. The value appears strong and on an upward trend. It has increased from -18.64 Cr. (Sep 2025) to 0.92 Cr., marking an increase of 19.56 Cr..
- For Tax %, as of Dec 2025, the value is 59.78%. The value appears to be increasing, which may not be favorable. It has increased from -17.17% (Sep 2025) to 59.78%, marking an increase of 76.95%.
- For Net Profit, as of Dec 2025, the value is 0.37 Cr.. The value appears strong and on an upward trend. It has increased from -15.44 Cr. (Sep 2025) to 0.37 Cr., marking an increase of 15.81 Cr..
- For EPS in Rs, as of Dec 2025, the value is 0.36. The value appears strong and on an upward trend. It has increased from -3.99 (Sep 2025) to 0.36, marking an increase of 4.35.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 25, 2026, 5:46 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,231 |
| Expenses | 35 | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,283 |
| Operating Profit | -4 | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -19 | -52 |
| OPM % | -15% | -19% | -31% | -15% | -8% | -15% | -13% | -2% | 62% | -10% | -2% | -2% | -4% |
| Other Income | 0 | 2 | -0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 66 |
| Interest | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 0 |
| Depreciation | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 6 |
| Profit before tax | -7 | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | 8 |
| Tax % | -5% | -0% | -1% | 2% | 19% | 3% | -9% | 4% | 22% | -19% | -119% | -34% | |
| Net Profit | -6 | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | 29 |
| EPS in Rs | -2.03 | -4.68 | -11.51 | -9.00 | -3.73 | -11.81 | -12.19 | -3.27 | 197.05 | -22.70 | 2.79 | -28.66 | 8.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -150.00% | -146.67% | 21.62% | 48.28% | -186.67% | -20.93% | 67.31% | 5188.24% | -111.45% | 106.06% | -2333.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | 3.33% | 168.29% | 26.65% | -234.94% | 165.74% | 88.24% | 5120.93% | -5299.68% | 217.51% | -2439.39% |
Sastasundar Ventures Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 23% |
| 3 Years: | -15% |
| TTM: | -13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 24% |
| 3 Years: | 44% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 24% |
| 3 Years: | -7% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -2% |
| 3 Years: | -1% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 1:26 pm
Balance Sheet
Last Updated: December 4, 2025, 1:56 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 238 | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 650 |
| Borrowings | 0 | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 5 |
| Other Liabilities | 39 | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 321 |
| Total Liabilities | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
| Fixed Assets | 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 41 | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 633 |
| Other Assets | 151 | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 257 |
| Total Assets | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
Below is a detailed analysis of the balance sheet data for Sastasundar Ventures Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 32.00 Cr..
- For Reserves, as of Sep 2025, the value is 650.00 Cr.. The value appears strong and on an upward trend. It has increased from 638.00 Cr. (Mar 2025) to 650.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 4.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 321.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 300.00 Cr. (Mar 2025) to 321.00 Cr., marking an increase of 21.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,008.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 970.00 Cr. (Mar 2025) to 1,008.00 Cr., marking an increase of 38.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 102.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 15.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 633.00 Cr.. The value appears strong and on an upward trend. It has increased from 575.00 Cr. (Mar 2025) to 633.00 Cr., marking an increase of 58.00 Cr..
- For Other Assets, as of Sep 2025, the value is 257.00 Cr.. The value appears to be declining and may need further review. It has decreased from 283.00 Cr. (Mar 2025) to 257.00 Cr., marking a decrease of 26.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,008.00 Cr.. The value appears strong and on an upward trend. It has increased from 970.00 Cr. (Mar 2025) to 1,008.00 Cr., marking an increase of 38.00 Cr..
Notably, the Reserves (650.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.00 | -15.00 | -47.00 | -41.00 | -25.00 | -35.00 | -60.00 | -22.00 | -1.00 | -116.00 | -28.00 | -20.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 169 | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 |
| Inventory Days | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 | |
| Days Payable | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 | |
| Cash Conversion Cycle | 169 | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 |
| Working Capital Days | 441 | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 |
| ROCE % | -2% | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% | -3% | -1% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal S&P BSE Healthcare ETF | 78 | 0.03 | 0 | 78 | 2025-04-22 17:25:21 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -28.66 | 2.79 | -22.70 | 222.73 | -3.27 |
| Diluted EPS (Rs.) | -28.66 | 2.79 | -22.70 | 222.73 | -3.27 |
| Cash EPS (Rs.) | -36.75 | 31.80 | -2.00 | 310.50 | -3.97 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 210.58 | 314.21 | 312.34 | 379.59 | 72.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 210.58 | 314.21 | 312.34 | 379.59 | 72.11 |
| Revenue From Operations / Share (Rs.) | 349.24 | 432.47 | 326.88 | 198.50 | 172.33 |
| PBDIT / Share (Rs.) | 1.20 | 20.69 | -6.39 | -11.64 | -3.41 |
| PBIT / Share (Rs.) | -0.63 | 17.82 | -8.96 | -12.95 | -4.82 |
| PBT / Share (Rs.) | -60.63 | 17.50 | -11.74 | 350.41 | -5.14 |
| Net Profit / Share (Rs.) | -38.58 | 28.93 | -4.58 | 309.19 | -5.37 |
| NP After MI And SOA / Share (Rs.) | -28.66 | 2.79 | -22.70 | 222.73 | -3.27 |
| PBDIT Margin (%) | 0.34 | 4.78 | -1.95 | -5.86 | -1.97 |
| PBIT Margin (%) | -0.18 | 4.12 | -2.74 | -6.52 | -2.79 |
| PBT Margin (%) | -17.35 | 4.04 | -3.59 | 176.53 | -2.98 |
| Net Profit Margin (%) | -11.04 | 6.68 | -1.40 | 155.76 | -3.11 |
| NP After MI And SOA Margin (%) | -8.20 | 0.64 | -6.94 | 112.20 | -1.89 |
| Return on Networth / Equity (%) | -13.60 | 1.16 | -9.58 | 78.01 | -5.20 |
| Return on Capital Employeed (%) | -0.22 | 5.22 | -2.54 | -3.34 | -6.57 |
| Return On Assets (%) | -9.35 | 0.77 | -5.98 | 55.44 | -3.55 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Asset Turnover Ratio (%) | 1.05 | 1.17 | 0.83 | 0.00 | 0.00 |
| Current Ratio (X) | 9.18 | 15.51 | 12.60 | 24.93 | 2.70 |
| Quick Ratio (X) | 7.92 | 13.72 | 10.42 | 22.48 | 1.41 |
| Inventory Turnover Ratio (X) | 9.83 | 0.01 | 0.02 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 17.56 | 65.23 | -23.42 | -22.63 | -10.34 |
| Interest Coverage Ratio (Post Tax) (X) | 313.57 | 92.19 | -6.61 | -105.30 | -15.29 |
| Enterprise Value (Cr.) | 954.10 | 1152.85 | 745.44 | 1220.42 | 397.22 |
| EV / Net Operating Revenue (X) | 0.85 | 0.83 | 0.71 | 1.93 | 0.72 |
| EV / EBITDA (X) | 250.15 | 17.51 | -36.68 | -32.96 | -36.63 |
| MarketCap / Net Operating Revenue (X) | 0.69 | 0.70 | 0.67 | 1.80 | 0.67 |
| Price / BV (X) | 1.15 | 1.27 | 0.92 | 1.25 | 1.85 |
| Price / Net Operating Revenue (X) | 0.69 | 0.70 | 0.67 | 1.80 | 0.67 |
| EarningsYield | -0.11 | 0.01 | -0.10 | 0.62 | -0.02 |
After reviewing the key financial ratios for Sastasundar Ventures Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -28.66. This value is below the healthy minimum of 5. It has decreased from 2.79 (Mar 24) to -28.66, marking a decrease of 31.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is -28.66. This value is below the healthy minimum of 5. It has decreased from 2.79 (Mar 24) to -28.66, marking a decrease of 31.45.
- For Cash EPS (Rs.), as of Mar 25, the value is -36.75. This value is below the healthy minimum of 3. It has decreased from 31.80 (Mar 24) to -36.75, marking a decrease of 68.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.58. It has decreased from 314.21 (Mar 24) to 210.58, marking a decrease of 103.63.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.58. It has decreased from 314.21 (Mar 24) to 210.58, marking a decrease of 103.63.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 349.24. It has decreased from 432.47 (Mar 24) to 349.24, marking a decrease of 83.23.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 2. It has decreased from 20.69 (Mar 24) to 1.20, marking a decrease of 19.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.63. This value is below the healthy minimum of 0. It has decreased from 17.82 (Mar 24) to -0.63, marking a decrease of 18.45.
- For PBT / Share (Rs.), as of Mar 25, the value is -60.63. This value is below the healthy minimum of 0. It has decreased from 17.50 (Mar 24) to -60.63, marking a decrease of 78.13.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -38.58. This value is below the healthy minimum of 2. It has decreased from 28.93 (Mar 24) to -38.58, marking a decrease of 67.51.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -28.66. This value is below the healthy minimum of 2. It has decreased from 2.79 (Mar 24) to -28.66, marking a decrease of 31.45.
- For PBDIT Margin (%), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 10. It has decreased from 4.78 (Mar 24) to 0.34, marking a decrease of 4.44.
- For PBIT Margin (%), as of Mar 25, the value is -0.18. This value is below the healthy minimum of 10. It has decreased from 4.12 (Mar 24) to -0.18, marking a decrease of 4.30.
- For PBT Margin (%), as of Mar 25, the value is -17.35. This value is below the healthy minimum of 10. It has decreased from 4.04 (Mar 24) to -17.35, marking a decrease of 21.39.
- For Net Profit Margin (%), as of Mar 25, the value is -11.04. This value is below the healthy minimum of 5. It has decreased from 6.68 (Mar 24) to -11.04, marking a decrease of 17.72.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -8.20. This value is below the healthy minimum of 8. It has decreased from 0.64 (Mar 24) to -8.20, marking a decrease of 8.84.
- For Return on Networth / Equity (%), as of Mar 25, the value is -13.60. This value is below the healthy minimum of 15. It has decreased from 1.16 (Mar 24) to -13.60, marking a decrease of 14.76.
- For Return on Capital Employeed (%), as of Mar 25, the value is -0.22. This value is below the healthy minimum of 10. It has decreased from 5.22 (Mar 24) to -0.22, marking a decrease of 5.44.
- For Return On Assets (%), as of Mar 25, the value is -9.35. This value is below the healthy minimum of 5. It has decreased from 0.77 (Mar 24) to -9.35, marking a decrease of 10.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.05. It has decreased from 1.17 (Mar 24) to 1.05, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 9.18. This value exceeds the healthy maximum of 3. It has decreased from 15.51 (Mar 24) to 9.18, marking a decrease of 6.33.
- For Quick Ratio (X), as of Mar 25, the value is 7.92. This value exceeds the healthy maximum of 2. It has decreased from 13.72 (Mar 24) to 7.92, marking a decrease of 5.80.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.83. This value exceeds the healthy maximum of 8. It has increased from 0.01 (Mar 24) to 9.83, marking an increase of 9.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 17.56. This value is within the healthy range. It has decreased from 65.23 (Mar 24) to 17.56, marking a decrease of 47.67.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 313.57. This value is within the healthy range. It has increased from 92.19 (Mar 24) to 313.57, marking an increase of 221.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 954.10. It has decreased from 1,152.85 (Mar 24) to 954.10, marking a decrease of 198.75.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.83 (Mar 24) to 0.85, marking an increase of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 250.15. This value exceeds the healthy maximum of 15. It has increased from 17.51 (Mar 24) to 250.15, marking an increase of 232.64.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 24) to 0.69, marking a decrease of 0.01.
- For Price / BV (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.27 (Mar 24) to 1.15, marking a decrease of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 24) to 0.69, marking a decrease of 0.01.
- For EarningsYield, as of Mar 25, the value is -0.11. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.11, marking a decrease of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sastasundar Ventures Ltd:
- Net Profit Margin: -11.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -0.22% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -13.6% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 313.57
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 7.92
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.6 (Industry average Stock P/E: 102.88)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -11.04%
About the Company - Qualitative Analysis
Sastasundar Ventures Ltd. is a Public Limited Listed company incorporated on 06/06/1989 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L65993WB1989PLC047002 and registration number is 047002. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 0.40 Cr. and Equity Capital is Rs. 31.81 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | Azimganj House, 2nd Floor, Kolkata West Bengal 700017 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Banwari Lal Mittal | Chairman & Managing Director |
| Mrs. Abha Mittal | Non Executive Director |
| Mr. Ravi Kant Sharma | Non Executive Director |
| Mrs. Rupanjana De | Independent Director |
| Dr. J N Mukhopadhyaya | Independent Director |
| Mrs. Anjana Dikshit | Independent Director |
FAQ
What is the intrinsic value of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd's intrinsic value (as of 15 March 2026) is ₹148.08 which is 47.49% lower the current market price of ₹282.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹897 Cr. market cap, FY2025-2026 high/low of ₹375/230, reserves of ₹650 Cr, and liabilities of ₹1,008 Cr.
What is the Market Cap of Sastasundar Ventures Ltd?
The Market Cap of Sastasundar Ventures Ltd is 897 Cr..
What is the current Stock Price of Sastasundar Ventures Ltd as on 15 March 2026?
The current stock price of Sastasundar Ventures Ltd as on 15 March 2026 is ₹282.
What is the High / Low of Sastasundar Ventures Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sastasundar Ventures Ltd stocks is ₹375/230.
What is the Stock P/E of Sastasundar Ventures Ltd?
The Stock P/E of Sastasundar Ventures Ltd is 34.6.
What is the Book Value of Sastasundar Ventures Ltd?
The Book Value of Sastasundar Ventures Ltd is 214.
What is the Dividend Yield of Sastasundar Ventures Ltd?
The Dividend Yield of Sastasundar Ventures Ltd is 0.00 %.
What is the ROCE of Sastasundar Ventures Ltd?
The ROCE of Sastasundar Ventures Ltd is 1.33 %.
What is the ROE of Sastasundar Ventures Ltd?
The ROE of Sastasundar Ventures Ltd is 4.63 %.
What is the Face Value of Sastasundar Ventures Ltd?
The Face Value of Sastasundar Ventures Ltd is 10.0.